source
- Teva R&D chief Eric Hughes resigns as company pushes innovative medicines expansionTeva Pharmaceutical announced that its head of research and development, Eric Hughes, M.D., Ph.D., will resign, with his departure set to occur over the next few months. Hughes joined Teva in 2022…
- Drugmakers urged to assess device capabilities and engage regulators early for combo productsAt the AFDO/RAPS Combination Products Summit, a panel of experts advised drugmakers that developing standalone medical devices to be used with their drugs requires careful evaluation of the devices…